Results 161–180 of 1084 for speaker:Chris Green

Written Answers — Department of Health and Social Care: National Institute for Health Research: Clinical Trials (28 Mar 2022)

Chris Green: To ask the Secretary of State for Health and Social Care, how many participants were recruited into NIHR supported phase 3 trials for (a) dementia, (b) cancer, (c) stroke and (d) coronary heart disease over the last 10 years.

Written Answers — Department for Business, Energy and Industrial Strategy: Global Britain Investment Fund: Drugs (15 Mar 2022)

Chris Green: To ask the Secretary of State for Business, Energy and Industrial Strategy, when the Global Britain Investment Fund will open for investment for new medicines manufacturing; and what steps he is taking to ensure that the fund supports innovative, smaller biotechnology companies.

Written Answers — Department of Health and Social Care: Clinical Trials (14 Mar 2022)

Chris Green: To ask the Secretary of State for Health and Social Care, what progress he has made on the implementation of the proposals in his Department's policy paper, Saving and Improving Lives: The Future of UK Clinical Research Delivery; and what funding has been allocated to the longer-term implementation of those proposals.

Written Answers — Department of Health and Social Care: Clinical Trials (14 Mar 2022)

Chris Green: To ask the Secretary of State for Health and Social Care, if he will take steps to implement the strategy set out in his Department's policy paper, Saving and Improving Lives: The Future of UK Clinical Research Delivery, to ensure the attractiveness of the UK for early-stage clinical trials.

Written Answers — Department of Health and Social Care: Breast Cancer: Drugs ( 7 Mar 2022)

Chris Green: To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 11 January 2022 to Question 96909, on Cancer: Drugs, how many breast cancer drugs are being assessed through the Project Orbis licensing route.

Written Answers — Department of Health and Social Care: Genetics: Screening ( 1 Feb 2022)

Chris Green: To ask the Secretary of State for Health and Social Care, what assessment he has made of the (a) technology capability and (b) workforce expertise in each of the genomic laboratory hubs; and if he will publish that assessment.

Vaccination: Condition of Deployment (31 Jan 2022)

Chris Green: I welcome my right hon. Friend’s statement. He made several references to conditions of employment and he finished by asking regulators, “to urgently review current guidance to registrants on vaccinations”. What will he do to ensure that that does not become a compulsion for vaccinations by other means?

Written Answers — Department of Health and Social Care: National Institute for Health and Care Excellence (31 Jan 2022)

Chris Green: To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 11 January 2022 to Question 96910 on National Institute for Health and Care Excellence, how many oncology technical appraisals have been rescheduled in the last six months directly as a result of NICE operational challenges; and what the average time taken has been to reschedule those appraisals.

Written Answers — Treasury: Research: Tax Allowances (12 Jan 2022)

Chris Green: To ask the Chancellor of the Exchequer, when he plans to publish his Department's response to its consultation entitled R&D Tax Reliefs.

Written Answers — Treasury: Research: Tax Allowances (12 Jan 2022)

Chris Green: To ask the Chancellor of the Exchequer, whether he has made an assessment of the potential effect on research and development tax relief of territoriality restrictions having been in place for each of the last five years, by sector.

Written Answers — Treasury: Research: Tax Allowances (12 Jan 2022)

Chris Green: To ask the Chancellor of the Exchequer, what discussions he has had with the life sciences sector to discuss the issue of territoriality for R&D tax relief.

Written Answers — Department for Business, Energy and Industrial Strategy: Life Sciences: Clinical Trials (11 Jan 2022)

Chris Green: To ask the Secretary of State for Business, Energy and Industrial Strategy, whether he has made an assessment of the potential effect of the UK's regulatory framework on the number of life sciences companies that deem it necessary to conduct clinical trials outside of the UK; and whether he has plans to make exceptions under the existing framework to enable more UK-based life science...

Written Answers — Department of Health and Social Care: National Institute for Health and Care Excellence (11 Jan 2022)

Chris Green: To ask the Secretary of State for Health and Social Care, what discussions his Department has had with NICE on their (a) current and (b) future capacity to deliver final draft guidance on medicines within three months of regulatory approval by the MHRA.

Written Answers — Department of Health and Social Care: National Institute for Health and Care Excellence (11 Jan 2022)

Chris Green: To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of the MHRA joining the Project Orbis scheme in January 2021 on the speed of patient access to new oncology medicines.

Written Answers — Department of Health and Social Care: National Institute for Health and Care Excellence (11 Jan 2022)

Chris Green: To ask the Secretary of State for Health and Social Care, what assessment he has made of the impact of operational challenges faced by NICE on its ability to deliver timely patient access to new medicines.

Written Answers — Department of Health and Social Care: Coronavirus: Screening (23 Dec 2021)

Chris Green: To ask the Secretary of State for Health and Social Care, if he will publish data on the number of covid-19 (a) tests delivered and (b) patients referred to each genomic laboratory hub in the 12 months for which that data is available.

Written Answers — Department of Health and Social Care: Kidney Diseases: Dialysis Machines (17 Dec 2021)

Chris Green: To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the variation in survival rates for patients receiving dialysis at home compared to those receiving it in-centre.

Written Answers — Department of Health and Social Care: Kidney Diseases: Dialysis Machines (17 Dec 2021)

Chris Green: To ask the Secretary of State for Health and Social Care, how many patients from lower socio-economic backgrounds have received kidney dialysis treatment at home in the last five years compared to patients from higher socio-economic backgrounds.

Written Answers — Department of Health and Social Care: Kidney Diseases: Dialysis Machines (17 Dec 2021)

Chris Green: To ask the Secretary of State for Health and Social Care, what assessment he has made of the variation in access to home kidney dialysis for patients from Black, Asian or minority ethnicity backgrounds compared to patients from other backgrounds; and what assessment he has made of the reasons for that variation.

Written Answers — Department of Health and Social Care: National Institute for Health and Care Excellence (15 Dec 2021)

Chris Green: To ask the Secretary of State for Health and Social Care, if he will ask NICE to undertake an analysis of whether its proposed new methods for assessing medicines will improve the access of NHS patients to new treatment in comparison to other developed countries in Europe.


<< < 1 2 3 4 5 6 7 8 9 10 > >>

Create an alert

Advanced search

Find this exact word or phrase

You can also do this from the main search box by putting exact words in quotes: like "cycling" or "hutton report"

By default, we show words related to your search term, like “cycle” and “cycles” in a search for cycling. Putting the word in quotes, like "cycling", will stop this.

Excluding these words

You can also do this from the main search box by putting a minus sign before words you don’t want: like hunting -fox

We also support a bunch of boolean search modifiers, like AND and NEAR, for precise searching.

Date range

to

You can give a start date, an end date, or both to restrict results to a particular date range. A missing end date implies the current date, and a missing start date implies the oldest date we have in the system. Dates can be entered in any format you wish, e.g. 3rd March 2007 or 17/10/1989

Person

Enter a name here to restrict results to contributions only by that person.

Section

Restrict results to a particular parliament or assembly that we cover (e.g. the Scottish Parliament), or a particular type of data within an institution, such as Commons Written Answers.

Column

If you know the actual Hansard column number of the information you are interested in (perhaps you’re looking up a paper reference), you can restrict results to that; you can also use column:123 in the main search box.